[Drug therapy of infections in hematologic disorders ].
Funada
H
H
Protected Environment Unit, Kanazawa University School of Medicine.
D000666:Amphotericin B / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy* / Q000209:etiology / Q000628:therapy; D004359:Drug Therapy, Combination; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006098:Granulocytes; D006402:Hematologic Diseases / Q000150:complications*; D006801:Humans; D007970:Leukopenia / Q000150:complications; D009181:Mycoses / Q000188:drug therapy / Q000209:etiology; D018805:Sepsis / Q000188:drug therapy* / Q000209:etiology / Q000628:therapy; D005719:gamma-Globulins / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D005719:gamma-Globulins; D016179:Granulocyte Colony-Stimulating Factor; D000666:Amphotericin B